A107G (p.Ala107Gly) variant of ATRX (Chromatin remodeler ATRX)

A107G (p.Ala107Gly) in ATRX (Chromatin remodeler ATRX) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.34 / 1. The record also includes population frequency data and structural context.

A107G (p.Ala107Gly) variant details